Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Emergent_BioSolutions
|
| gptkbp:acquisitionYear |
2018
|
| gptkbp:country |
gptkb:Ireland
|
| gptkbp:focus |
treatment of opioid overdose
|
| gptkbp:foundedIn |
2014
|
| gptkbp:founder |
gptkb:Seamus_Mulligan
|
| gptkbp:headquartersLocation |
gptkb:Dublin,_Ireland
|
| https://www.w3.org/2000/01/rdf-schema#label |
Adapt Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:notableProduct |
gptkb:Narcan
|
| gptkbp:productType |
naloxone nasal spray
|
| gptkbp:website |
https://www.adaptpharma.com/
|
| gptkbp:bfsParent |
gptkb:Emergent_BioSolutions
|
| gptkbp:bfsLayer |
5
|